key: cord-0828666-nghvn605
authors: Söderlund-Venermo, Maria; Varma, Anupam; Guo, Deyin; Gladue, Douglas P.; Poole, Emma; Pujol, Flor H.; Pappu, Hanu; Romalde, Jesús L.; Kramer, Laura; Baz, Mariana; Venter, Marietjie; Moore, Matthew D.; Nevels, Michael M.; Ezzikouri, Sayeh; Vakharia, Vikram N.; Wilson, William C.; Malik, Yashpal Singh; Shi, Zhengli; Abdel-Moneim, Ahmed S.
title: World Society for Virology first international conference: Tackling global virus epidemics
date: 2021-12-06
journal: Virology
DOI: 10.1016/j.virol.2021.11.009
sha: 21fd2ce6cd2fc1a3048591034f20d1e1fdd97eb2
doc_id: 828666
cord_uid: nghvn605

This communication summarizes the presentations given at the 1st international conference of the World Society for Virology (WSV) held virtually during 16–18 June 2021, under the theme of tackling global viral epidemics. The purpose of this biennial meeting is to foster international collaborations and address important viral epidemics in different hosts. The first day included two sessions exclusively on SARS-CoV-2 and COVID-19. The other two days included one plenary and three parallel sessions each. Last not least, 16 sessions covered on-demand submitted talks. In total, 270 scientists from 49 countries attended the meeting, including 40 invited keynote speakers.

General information about the conference Institute, New Delhi, India (Varma, 2021a) . The cost of participation was kept comparatively low so scientists from low-income countries could participate. The fact that we had to take into account a global audience and speakers from around the world was challenging due to the dramatically different time zones. All presentations were furthermore recorded and remained open to conference participants for 30 days. An Abstract book is available online (WSV2021-Abstracts, 2021).

We were proud and happy that altogether 40 distinguished Keynote speakers, who are all top experts in their fields, covered areas of global interest to virology (Table 1) . We were further pleased to receive over 140 exciting abstract submissions, which were divided into 16 sessions of 1-2 hours, under 5 themes: SARS-CoV-2, Human, Zoonotic, Animal and Plant viruses.

Unfortunately, these submitted talks were too many to fit into the live 4-hour window, so they were kept as pre-recorded on-demand talks. However, questions for authors could be submitted through our platform Q&A panel. Because of the multitude of talks in only three days of conference, we decided to record all sessions to allow viewing for one month.

J o u r n a l P r e -p r o o f program of the UK has been highly successful but not perfect. The vaccine efficacy was 50.2% and 33.2% following the first vaccine dose but increased following the second dose to 88.4% and 80.8% against Alpha and Delta, respectively Volz et al., 2021) Jerome Kim, International Vaccine Institute, Seoul, South Korea, presented a critical overview on vaccines and the significance of their efficacy. There is a challenge between the proof of efficacy and impact as well as the successful mitigation of the burden of COVID-19 disease globally. To achieve 70% global coverage, the world needs 10-14 billion doses of COVID-19 vaccines. Accordingly, logistics and human capacity to ship, store, and administer COVID-19 vaccines need to be strengthened globally. A multivalent variant vaccine with optimized dose/schedule that correlates with protection and effectiveness is the current global challenge.

The message from these presentations is that we must go beyond the immediate health crisis of COVID-19 management and aim for sustainable long-term solutions (Figueroa et al., 2021; Hotez et al., 2021) .

The second plenary session, chaired by Ziad Memish, College of Medicine, Alfaisal University, Saudi Arabia, and Ilkka Julkunen, Institute of Biomedicine, University of Turku, Finland, concentrated on the development of laboratory animal models, molecular pathogenesis and the immune response to SARS-CoV-2, as well as clinical evaluation and management of "long-COVID".

Stanley Perlman, University of Iowa, Iowa, USA, presented the development of mouse models for studying COVID-19 pathogenesis. Mice are modified to express hACE2 by Ad5-hACE2 transduction, hACE2-Tg mice, hACE2-knock-in mice or modify the virus so that it can bind to mACE2. Both approaches require 1-2 amino acid changes in mACE2 or SARS-CoV-2 to change virus/receptor-binding affinity. Mice infected with this virus are not only useful for studying the pathogenesis of COVID-19 in the lungs, but also for other manifestations, including anosmia and ageusia (Wong et al., 2020; Zheng et al., 2021) . COVID. Post-COVID involves several organs, including the brain, lungs, heart or skin.

However, the underlying mechanisms of long-COVID are still unknown and require a multidisciplinary approach combining the clinic and laboratory to improve our understanding and treatment of this disease (Tremblay et al., 2021) .

The main outcomes of the session highlight the benefit of using modified lab animals in studying virus pathogenesis and the identification of biomarkers that could block virus replication.

Understanding the immune responsiveness to SARS-CoV-2 and its vaccines is also of utmost importance to reach the best way for developing successful vaccines. (Gallo, 2020) .

The talks provided background on the pursuit by scientists to understand, prevent, and treat, harmful viruses and their spread; as well as also gain knowledge of viruses beneficial for the wellbeing of our planet.

In addition to the plenary talks discussed above, a number of parallel sessions were presented on a diverse set of topics from basic to applied aspects of viruses affecting humans, other animals, plants, and microbes, as well as numerous tools and treatments for these viruses. (Konakalla et al., 2021; Nilon et al., 2021) . James Van Etten, University of Nebraska, USA, showed that chloroviruses are unique viruses to encode enzymes that synthesize extracellular polysaccharides and presented information on glycosylation of the major capsid protein (MCP), and characterization of the chlorovirusencoded glycosyltransferases (GTases) and methyltransferases (MTases) involved in glycosylation. Genetic, structural, and hydrolytic analyses indicate that protein A111/114R, which is conserved in all chloroviruses, is a GTase with three domains: galactosyltransferase, xylosyltransferase, and fucosyltransferase (Noel et al., 2021; Speciale et al., 2020) . technology, for homogenous, wash-free, rapid, and highly specific and sensitive immunodiagnostics (IgM, IgG and/or antigen detection), in both serum and urine. So far, the technique has been used for the serology of Puumala, B19V, Zika and SARS-CoV-2 virus infections and coeliac disease (IgA) (Rusanen et al., 2021a; Rusanen et al., 2021b) .

Evgeny Nikolaev, Skolkovo Institute of Science and Technology, Skolkova, Moscow, Russia, reported on a mass-spectrometry (MS)-based fast and sensitive method for detection of the N protein of SARS-CoV-2 in patient samples utilizing a simple preparation procedure, including tryptic digestion of the eluate sediment from swab samples. Interestingly, MS approaches can be created for detection of both viral and human proteins in various physiological fluids to also study the human response to viral infections, such as in the case of prolonged "long-COVID" patients (Zakharova et al., 2021) .

Christina Wege, University of Stuttgart, Stuttgart, Germany, talked about plant viral nanoparticles with multivalent protein shells, which can serve as advantageous carrier scaffolds straight, branched or star-shaped TMV nanotubesfor displaying biomolecules for various purposes, including diagnostics. These versatile opportunities provided by TMV-based hybrid structures point at many potential uses, due to the easy handling and high availability of the natural plant-made building blocks (Jablonski et al., 2021; Poghossian et al., 2020) . Teresa de los Santos, Plum Island Animal Disease Center, Greenport NY, USA, summarized a body of work on the picornavirus foot-and-mouth disease virus (FMDV), a dreaded pathogen in cloven-hoofed animals. The FMDV leader proteinase (Lpro) affects the innate immune response including the expression of interferon-stimulated genes (ISGs). In addition to its conventional protease activity, Lpro acts as a deubiquitinase and deISGylase. Mutations in Lpro result in increased levels of the ubiquitin-like protein ISG15, which limit viral replication. This study highlights the potential use of Lpro mutants as live attenuated vaccine candidates and of ISG15 as an antiviral agent Visser et al., 2020) . J o u r n a l P r e -p r o o f Heikki Hyöty, Tampere University, Tampere, Finland, nicely reviewed and highlighted the strong link between the group B coxsackieviruses and type 1 diabetes, based on both epidemiological data and that they, in in vitro and in vivo studies, infect pancreatic beta-cells.

The first trials of a vaccine against the group B coxsackieviruses and antiviral drugs among diabetic patients are in progress and are foreseen to be promising strategies to prevent type 1 diabetes (Oikarinen et al., 2020a; Oikarinen et al., 2020b) . Stephanie Karst, University of Florida, Gainesville, FL, USA, described the suitability of murine norovirus as a model to study human norovirus pathogenesis, with special emphasis on the crosslink between host and environmental factors that regulate norovirus infection.

Interestingly, she discussed the consequences of norovirus infection of host immune cells, as well as the role host bile acid has in promoting and influencing norovirus pathogenesis [(Grau et al., 2020; Walker et al., 2021) . Mzia Kutateladze, Eliava Institute, Tbilisi, Georgia, talked about phage therapy, which was aimed to become a standard part of the healthcare systems in Eastern Europe and the USSR J o u r n a l P r e -p r o o f during the late 20 th century. Phages are widely and successfully used to treat acute and chronic infections caused by antibiotic-resistant bacteria (Poirel et al., 2020) .

In addition to the Keynote talks reviewed above, a total of 140 abstracts were also submitted to this conference, which were divided into 16 descriptive 1-2 h sessions according to the topics of the talks, belonging under 5 themes: SARS-CoV-2 & COVID-19, Human-, Zoonotic-, Animal/Veterinary-, and Plant Virology. Due to space constraints, further details are not presented here but can be found in (Supp1.) and the Abstract booklet of the meeting (WSV2021-Abstracts, 2021).

WSV 2021 came to a close with summary remarks by the WSV-President with thanks to all speakers, attendees, and sponsors (Varma, 2021b) . The WSV2021 conference clearly demonstrated the enormity of challenges in managing emerging and re-emerging viruses and the need for concerted efforts by all the virologists of the world to work for minimizing the global risk of emergence of new pathogenic human, animal or plant virus infections. A strong network of the academic societies is essential to engage with policy makers for greater and continued investment in virology research for the benefit of humanity and global health. WSV can play a key role in this effort along with additional national virology societies. The 2 nd WSV conference, WSV2023, is planned to be held in the city of Riga, Latvia, during 15-17 June 2023.

Immune responses upon in ovo HVT-IBD vaccination vary between different chicken lines

Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are

HIV/AIDS research for the future

Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target

The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type

Role of phylogenetic structure in the dynamics of coastal viral assemblages

Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic EClinicalMedicine 39

Capacitive field-effect biosensor studying adsorption of tobacco mosaic virus particles Micromachines

Naturally occurring animal coronaviruses as models for studying highly pathogenic human coronaviral disease

Induction of plant resistance in tobacco (Nicotiana tabacum) against tomato spotted wilt orthotospovirus through foliar application of dsRNA Viruses 13

Origins of SARS-CoV-2: window is closing for key scientific studies

WSV2021-Welcome Talk by Prof

Capsid proteins are necessary for replication of a parvovirus

Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure

Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections

Henipaviruses at the interface between bats, livestock and human population in

Impairment of the DeISGylation activity of foot-and-mouth disease virus Lpro causes attenuation in vitro and in vivo

Changing composition of SARS-CoV-2 lineages and rise of Delta variant

miRNAs in insects infected by animal and plant viruses Viruses 10

Primed CRISPR-Cas adaptation and impaired phage adsorption in Streptococcus mutans mSphere 6

Challenges and solutions to viral diseases of finfish in marine aquaculture Pathogens 10

Rapid generation of a recombinant genotype VIII Newcastle disease virus (NDV) using full-length synthetic cDNA

Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice PeerJ 8

Current status and potential of RNA interference for the management of tomato spotted wilt virus and thrips vectors Pathogens 10

The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms

Differential detection of encapsidated versus unencapsidated enterovirus RNA in samples containing pancreatic enzymes-relevance for diabetes studies Viruses 12

Enterovirus infections are associated with the development of celiac disease in a birth cohort study Front Immunol 11

The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology

Field-Effect Sensors for Virus Detection: From Ebola to SARS-CoV-2 and Plant Viral Enhancers Front Plant Sci 11

A phage-based decolonisation strategy against pan-resistant enterobacterial strains

HBV 2021: New therapeutic strategies against an old foe

mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition medRxiv

Neurotropism of enterovirus D68 isolates is independent of sialic acid and is not a recently acquired phenotype mBio 10

A 10-minute "mix and read" antibody assay for SARS-CoV-2 Viruses 13

A generic, scalable, and rapid time-resolved Förster resonance energy transfer-based assay for antigen detection-SARS-CoV-2 as a proof of concept mBio 12

Comparative pathogenesis of bovine and porcine respiratory coronaviruses in the animal host species and SARS-CoV-2 in humans

Consensus statement: Virus taxonomy in the age of metagenomics

WSV2021-Welcome Talk by Dr. Maria Söderlund-Venermo, the head of the scientific organizing committee and Vice President of the World Society for Virology (Europe)

Chlorovirus PBCV-1 protein A064R has three of the transferase activities necessary to synthesize its capsid protein N-linked glycans

Lessons learnt from the COVID-19 pandemic Front Public Health 9

West Nile virus in wildlife and nonequine domestic animals

The critical interspecies transmission barrier at the animal⁻human interface Trop Med

The Biobanque québécoise de la COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories PLoS One 16, e0245031. van der Vaart

WSV2021-Welcome Talk by

Closing Speech by WSV President: The first WSV conference (WSV2021)

Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppression

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England Nature

Norovirus evolution in immunodeficient mice reveals potentiated pathogenicity via a single nucleotide change in the viral capsid

Sensitization of non-permissive laboratory mice to SARS-CoV-2 with a replication-deficient adenovirus expressing human ACE2 STAR Protoc 1

Exogenous application of RNAi-inducing double-stranded RNA inhibits aphid-mediated transmission of a plant virus Front Plant Sci 10, 265. WSV2021-Abstracts

Mass spectrometry based proteome profiling of the exhaled breath condensate for lung cancer biomarkers search

Expanding the RNA virosphere by unbiased metagenomics

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice

We are extremely grateful for the help of our event organizers, Vetlink Conferences from South Africa; they were very flexible for our needs and requests. We would further like to thank our sponsors, who made this conference possible: Boehringer Ingelheim (Platinum Level Sponsor), NanoString Technologies Inc. (Gold), Optolane Technologies Inc (Gold), and Inqaba biotec